Business Standard

Thursday, February 13, 2025 | 11:26 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sun Pharma Advanced Research Company reports standalone net loss of Rs 68.40 crore in the September 2022 quarter

Image

Capital Market

Sales rise 13.17% to Rs 31.54 crore

Net Loss of Sun Pharma Advanced Research Company reported to Rs 68.40 crore in the quarter ended September 2022 as against net loss of Rs 55.14 crore during the previous quarter ended September 2021. Sales rose 13.17% to Rs 31.54 crore in the quarter ended September 2022 as against Rs 27.87 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales31.5427.87 13 OPM %-198.48-196.16 -PBDT-65.40-52.60 -24 PBT-68.40-55.14 -24 NP-68.40-55.14 -24

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 07 2022 | 4:26 PM IST

Explore News